Literature DB >> 20935691

Retinoblastoma: postenucleation orbital recurrence.

Muhammad Arif1, Ziaul Islam.   

Abstract

OBJECTIVE: The objective of this study was (i) to identify clinicopathological variables that significantly influence the frequency of postenucleation orbital recurrence and (ii) to create an awareness regarding follow-up, to pre-empt orbital recurrence.
DESIGN: Retrospective, case-controlled, longitudinal study. PARTICIPANTS: A total of 176 children with retinoblastoma who were admitted and treated at Khyber Teaching Hospital between August 1, 1978, and July 31, 1998.
METHODS: This study was undertaken by reviewing the appropriate charts. The data of children with primary enucleation were analyzed to extract cases of orbital recurrence.
RESULTS: The mean age was 3.8 years (range 1-10 years). Of 176 patients, 83 (47.3%) presented with proptosis and fungating mass. Of 136 patients who were enucleated, 80 (58.82%) presented with proptosis and fungating mass. The 31 patients who had been diagnosed as having had orbital recurrence had a mean age of 4.09 years. The duration between enucleation and orbital recurrence was 1-12 months in 28 patients (90.4%). Histopathology reports of only 8 patients (26%) could be traced. Follow-up was recorded in only 9.6% of cases.
CONCLUSIONS: The failure to identify clinical and pathological parameters in the course of the disease in retinoblastoma children results in human misery caused by poor follow-up and gross negligence.

Entities:  

Mesh:

Year:  2010        PMID: 20935691     DOI: 10.3129/i10-059

Source DB:  PubMed          Journal:  Can J Ophthalmol        ISSN: 0008-4182            Impact factor:   1.882


  2 in total

1.  Alterations in the RB1 gene in Pakistani patients with retinoblastoma using direct sequencing analysis.

Authors:  Saeeda Kalsoom; Muhammad Wasim; Sibtain Afzal; Muhammad Saqib Shahzad; Shaiqa Ramzan; Ali Raza Awan; Aftab Ahmed Anjum; Khushnooda Ramzan
Journal:  Mol Vis       Date:  2015-09-17       Impact factor: 2.367

2.  Orbital relapse of retinoblastoma in patients with high-risk histopathology features.

Authors:  Maria Vittoria Cicinelli; Swathi Kaliki
Journal:  Ther Adv Ophthalmol       Date:  2019-04-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.